quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:33:25·45d
SECFiling
West Pharmaceutical Services Inc. logo

West Pharmaceutical Services Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

WST· West Pharmaceutical Services Inc.
Health Care
Original source

Companies

  • WST
    West Pharmaceutical Services Inc.
    Health Care

Recent analyst ratings

  • Dec 2UpdateMorgan Stanley$285.00
  • Sep 15UpdateRothschild & Co Redburn$311.00
  • Jun 24UpdateBarclays$245.00
  • Mar 18UpdateEvercore ISI$275.00
  • Feb 14UpdateDeutsche Bank$250.00
  • Jan 8UpdateCitigroup$400.00

Related

  • SEC20h
    SEC Form 10-Q filed by West Pharmaceutical Services Inc.
  • SEC1d
    West Pharmaceutical Services Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR1d
    West Reports First-Quarter 2026 Results
  • PR15d
    West to Host First-Quarter 2026 Conference Call
  • INSIDER22d
    SEC Form 4 filed by Haugen Janet Brutschea
  • PR24d
    West Expands Dublin Facility to Support High-Volume Injectable Therapies, Including Diabetes and Obesity
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by West Pharmaceutical Services Inc.
  • SEC43d
    SEC Form DEFA14A filed by West Pharmaceutical Services Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022